Literature DB >> 3249924

Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment.

T Lind1, C Cederberg, H Forssell, M Olausson, L Olbe.   

Abstract

We have studied the relationship between reduction of gastric acid secretion and fasting plasma gastrin concentrations during once daily omeprazole treatment. Healthy subjects were given omeprazole for 5 days in daily doses of 5, 10, 20, 40, or 80 mg. Acid secretion and fasting gastrin concentration were measured 6 h (maximal omeprazole effect) and 24 h (minimal omeprazole effect) after the fifth omeprazole dose. Omeprazole in doses lower than 20 mg daily did not suppress pentagastrin-stimulated acid secretion in all subjects 6 h after dosing on the 5th day. Doses of 20-80 mg omeprazole, however, significantly reduced acid secretion 24 h after the fifth dose, the range being 36-76%. A relationship between degree of acid inhibition and fasting gastrin concentration was observed. However, acid secretion needed to be reduced by more than 80% before gastrin levels were clearly affected. This degree of acid inhibition was only achieved 6 h after administration of omeprazole in doses of 20 mg and higher. The inhibitory effect of omeprazole on acid secretion decreased 24 h after dosing. Thus, fasting gastrin concentrations were moderately increased in the beginning and normalized at the end of each 24-h period during treatment with daily doses of 20-80 mg omeprazole.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3249924     DOI: 10.3109/00365528809090202

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  17 in total

1.  Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors?

Authors:  E S Bonapace; R S Fisher; H P Parkman
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

2.  Long-term effects of elevated gastrin levels on calcitonin secretion.

Authors:  M F Erdogan; A Gursoy; M Kulaksizoglu
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

3.  Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens.

Authors:  L C Baak; J B Jansen; I Biemond; C B Lamers
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Omeprazole: gastrin and gastric data (August 1991)

Authors:  R G Berlin
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

5.  Tolerance to oral H2-receptor antagonists.

Authors:  C H Wilder-Smith; T Ernst; M Gennoni; B Zeyen; F Halter; H S Merki
Journal:  Dig Dis Sci       Date:  1990-08       Impact factor: 3.199

6.  Effect of enprostil on omeprazole-induced hypergastrinemia and inhibition of gastric acid secretion in peptic ulcer patients.

Authors:  A Tari; M Hamada; T Kamiyasu; K Sumii; K Haruma; M Inoue; S Kishimoto; G Kajiyama; J H Walsh
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

Review 7.  Chronic proton pump inihibitor therapy and calcium metabolism.

Authors:  Yu-Xiao Yang
Journal:  Curr Gastroenterol Rep       Date:  2012-12

Review 8.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

9.  Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man.

Authors:  J L Meijer; J B Jansen; L F Crobach; I Biemond; C B Lamers
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

10.  Omeprazole in elderly duodenal ulcer patients: relationship between reduction in gastric acid secretion and fasting plasma gastrin.

Authors:  T Lind; C Cederberg; M Olausson; L Olbe
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.